Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T wave and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.